Hélène Fourmanoir
Observed name: H Fourmanoir
Institutions: St. Vincent's Birmingham, Mayo Clinic, The University of Texas MD Anderson Cancer Center, Universität Hamburg, University of California, Los Angeles, Hospital General Universitario Gregorio Marañón, University of Alabama at Birmingham, Universitätsklinikum Erlangen, International Drug Development Institute (Belgium), USC Norris Comprehensive Cancer Center, University of Pittsburgh Medical Center, Puma Biotechnology (United States), International Drug Development, Cepheid (United States)
Observed institutions: St. Vincent's Birmingham, Mayo Clinic, The University of Texas MD Anderson Cancer Center, Universität Hamburg, University of California, Los Angeles, Hospital General Universitario Gregorio Marañón, University of Alabama at Birmingham, Universitätsklinikum Erlangen, International Drug Development Institute (Belgium), USC Norris Comprehensive Cancer Center, University of Pittsburgh Medical Center, Puma Biotechnology (United States), International Drug Development, Cepheid (United States)
OpenAlex ID: A5035201349